Related Experiment Videos
Transcriptomic crossroads: Decoding genes and pathways that connect alopecia areata with chronic inflammatory skin
Hadis Abdolahzadeh1, Sabrina Henne1, Amir Mokhlesi2
1Institute of Human Genetics, School of Medicine, University Hospital Bonn, University of Bonn, Bonn, Germany.
Summary
Alopecia areata (AA) co-occurrence with skin disorders is not coincidental. Gene expression analysis reveals shared pathways, suggesting distinct subtypes and potential drivers like catecholamine signaling or skin barrier defects.
Area of Science:
- Immunodermatology
- Genomics
- Molecular Biology
Background:
- Alopecia areata (AA) is an immune-mediated hair loss condition.
- AA frequently co-occurs with chronic inflammatory skin disorders like atopic dermatitis, vitiligo, and psoriasis.
- These comorbidities may represent distinct AA subtypes with unique causes, but molecular data is lacking.
Purpose of the Study:
- To investigate the molecular underpinnings of comorbid alopecia areata (AA) with chronic inflammatory skin disorders.
- To identify shared gene expression signatures between AA and atopic dermatitis, vitiligo, and psoriasis.
- To explore potential etiological drivers for distinct comorbid AA subtypes.
Main Methods:
- Integrative analysis of publicly available case-control gene expression datasets.
- Analysis included data from alopecia areata, atopic dermatitis, vitiligo, and psoriasis cohorts.
- Bioinformatic approaches were used to identify overlapping gene expression signatures.
Main Results:
- A statistically significant overlap in gene expression signatures was found between alopecia areata (AA) and each of the studied chronic inflammatory skin disorders.
- Shared signatures suggest that the co-occurrence of these conditions is not random.
- Specific pathways implicated include catecholamine signaling and pigmentation processes (AA/vitiligo), and skin barrier defects/immune dysregulation (AA/atopic dermatitis or psoriasis).
Conclusions:
- The co-occurrence of alopecia areata (AA) with specific chronic inflammatory skin disorders is molecularly supported.
- Distinct comorbid AA subtypes may be driven by different etiological factors, including signaling pathways and immune responses.
- This research lays the groundwork for understanding complex interactions between skin, hair follicles, and the immune system in AA pathogenesis.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:23Skin Diseases and Disorders
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...